Author: admin

A study finds an association between a lower labour productivity and the painful symptoms of anxiety and depression.

|

a study finds an association between a lower labour productivity and the painful symptoms of anxiety and depression.

Results of a further 900 primary care patients with anxiety widespread. Spanish study

-generalized anxiety is the second most common primary care mental illness

-A Spanish research indicates the frequency of painful symptoms associated with anxiety

-59% of patients with generalized anxiety referred pain. This figure rises to 78% in patients presenting with anxiety and depression

Madrid, October 2009.- the painful symptoms associated with anxiety and depression are associated with a reduction in the productivity of the patients in 3.9 days per week. In addition, only 4.6% of the patients with generalized anxiety and depression are normal functionality when there are these painful symptoms. These are the results from a Spanish study in primary care patients.

The study, the first of these features is carried out in Spain, analyzed a total of 7.152 patients who attend primary health care for any reason, of which more than 13% (981) showed generalized anxiety, which confirms this disorder as the second most common primary care mental illness. In addition, more than half of these patients (559) presented one major depressive disorder and anxiety disorder.

Also analyzed the presence of painful somatic symptoms in these cases. 59% Of patients with generalized anxiety referred pain, figure that rises to 78% when anxiety joins depression.

“ In this study we found that the presence of painful symptoms in patients with generalized anxiety is very common, as we know it occurs in patients with depression ”, noted Dr. Ángel Luis Montejo, University Hospital of Salamanca and one of the researchers of the study. “ But perhaps more important, is that their presence is associated with a clear worse performance. Therefore, when treating a patient with anxiety widespread, so if you have or not associated depression, would be necessary to assess the presence of these painful symptoms during treatment and follow-up. ”

the influence of the painful symptoms

the results of the study show that painful somatic symptoms in patients with generalized anxiety relate directly on its functionality and productivity. The Group of patients with anxiety and painful symptoms, 88.8% had normal functionality. If compared with the group that showed no pain, this percentage is reduced to 39.9%.

In patients with depression and generalized anxiety, only 4.6 per cent of them had a normal functionality. On the other hand, the figure rises to 38% in patients who related anxiety and depression, but not painful symptoms.

In addition, patients with generalized anxiety accompanied by painful symptoms showed lower productivity, measured in days per week, than those who did not have them (2.3 days / week from low productivity to 1.1). This difference was most notable in patients with anxiety and depression with painful symptoms (3.9 days / week from low productivity) in relation to those with no pain (1.9 days / week from low productivity).

Characteristics of the study

The study was prepared by the doctors A. l. Montejo, Professor of the Faculty of Medicine of the University of Salamanca; (F) Knight, Department of research in Madrid Madrid service primary care; L Knight, Dept. of Psychiatry of the Hospital Puerta de Hierro Madrid; J. Arbesú, Center of health in Eria, Oviedo; as well as Irene Romera and immaculate Gilaberte, the Department’s research clinic of Lilly Spain.

During the dates in which the study was conducted was a first screening to detect patients with anxiety, according to the subscale of anxiety of the hospital level of depression and anxiety (HADS-A). The diagnosis was confirmed with the interview Neuropsiquiatrica international Mini (Mini International Neuropsychiatric Interview (M.I.N.I.). More than 7,000 initial patient, 981 presented generalized anxiety. This group was divided in turn into two arms to analyze the subgroup of patients presenting comorbidity with major depression (n = 559) and another subgroup with single generalized anxiety (n = 422). 336 Patients were included in the Group’s control, without anxiety and depression.

On Lilly

Lilly, a leader in innovation, is developing a growing portfolio of pharmaceutical products first and best in its class by applying the latest scientific developments in their laboratories around the world and its collaboration with different scientific organizations of recognized prestige. Headquartered in Indianapolis, Indiana (United States), Lilly provides answers – through medicines and information – to some of the most urgent medical needs of today’s world.

Read More

Researchers at the CIBERER presented his advances in diagnosis, therapy and transfer of research into rare diseases.

|

the CIBERER researchers presented their advances in diagnosis, therapy and transfer of research into diseases rarely.

– la III scientific annual meeting of the Center for biomedical research in network of rare diseases (CIBERER) takes place next Thursday and Friday, 29 and 30 October, in San Lorenzo del Escorial.

-the groups of this institution, which brings together the research of excellence in rare diseases in Spain, presented its progress in numerous groups of diseases.

-rare diseases are rare pathologies, which together constitute a major public health problem, affecting about 3 million Spaniards and are mostly chronic and disabling.

Valencia, October 2009.- Three researchers internationally will open this (iii) annual meeting. Dr. Juan Marugán (leader of team at the NIH Chemical Genomics Center, Rockville, USA) will present important innovations in the area of rare diseases of the National Institutes of Health (NIH), the largest institution of biomedical research worldwide. A great platform for genetic characterization with the aim of developing new therapies has been promoted from the NIH.

The Professor Zoya Elpeleg (Hebrew University Medical Center, Jerusalem) will present its progress in the discovery of new genes responsible for congenital disorders of the respiratory chain mitochondrial and Dr. Hannie Kremer (Centre for Molecular Life Science, Netherlands) will explain its advances in the study of sensorineural deafness.

In this same event later, staff CIBERER of all the groups that are part of the institution presented some of their gains in the genetic and molecular characterization, genetic counseling, proposals for therapy to the Charter or therapies, clinical trials. The progress in research on rare diseases in good part thanks to the collaborative project between the different research groups and other programs promoted since the CIBERER will be explained. Investigated diseases include disease Gaucher, Usher syndrome, the blistering Epidermolysis, spinal muscular atrophy, retinitis pigmentosa, albinism, disorders of the autistic spectrum, Fanconi’s anemia or Lafora disease, among many others.

The CIBERER will also present examples of progress in the transposition into clinical practice and the transfer to the productive sector of the rare disease research. The development of Secugen SL, a spin-off of a research group that focuses on genetic sequencing and molecular characterization will address. Research will also be explained on the Hereditaria hemorrhagic Telangiectasia as an example of translational research carried out within the CIBERER, with the participation of a group of basic research, a referral hospital and the Association that brings together the sick.

On the CIBERER

The center of biomedical research on rare diseases network – CIBERER-whose main objective is to promote translational research (for the application in clinical practice for the benefit of the patient) on rare diseases in Spain, is a pioneer in Europe and has few references on the international scene as a model of Consortium institution. Promoted by the Ministry of science and innovation through the Instituto de Salud Carlos III, he joined 30 mainly public institutions but also of the private sphere which investigated about rare diseases, managing, coordinating efforts and generating synergies between 61 groups of research and more than 700 scientists and researchers. The research of the CIBERER groups are the basic unit of operation.

CIBERER acts as a vehicle between biomedical research, health services and patients and families, being therapeutic conferences the channel through which doctors and patients associations are informed about the progress of ongoing investigations.

Also CIBERER supports and promotes actions aimed at providing research for rare diseases all services as they are to improve the human and material resources of the research groups; co-operation to promote synergies between the different groups; develop cooperative research projects and exploit new scientific hypotheses and technological developments; explain to society the value of research on rare diseases, helping to meet the needs of patients and families; and finally, to create bridges and collaborations with other research centres and pharmaceutical and biotechnology companies.

Read More
The classic days on medical prescription for the pharmaceutical Avenzoar Foundation returned to reap a great success of participation.

The classic days on medical prescription for the pharmaceutical Avenzoar Foundation returned to reap a great success of participation.

|

the classic days on medical prescription for the pharmaceutical Avenzoar Foundation returned to reap a great success of participation.

They met more than 200 students in their final years of medicine and pharmacy.

Sevilla, October 2009.- The classic days on medical prescription, which each year organizes the Avenzoar pharmaceutical Foundation in cooperation with the faculties of Pharmacy and medicine of Seville, and that they have counted on the collaboration of Abbott and AMA, returned to reap a great success of participation. Some 200 students of both degrees congregated in the Aula Magna of the Faculty of medicine to learn and discuss the medical prescription. The objective, promoting the professional collaboration of future doctors and pharmacists in their health care activity.

Antonio Gutiérrez (Medical College Vice President), Dr. José Luis Alcántara(Tesorero_Colegio_Médicos), Juan Ramón Lacalle (Dean Faculty of Medicine), Antonio Delgado (Avenzoar), Gabriel Gómez star Esther Tallón, Manuel Ojeda, Mercedes Fernández (Vice-Dean of Faculty of pharmacy), Jaime Román and Juan Pedro Vaquero.

By the College of pharmacists of Seville took part Secretary Juan Pedro Vaquero, who explained the different types of recipes, influencing the differences that exist between what makes legislation and what then happens in reality, and the Vice President Manuel Ojeda, he spoke of the electronic prescription and what it has meant for improvement for the medical practice both in care Primary at the pharmacy.

Juan Pedro Vaquero, Gabriel Gómez star, Esther Tallón, Ernesto Cortes (Abbot), Mercedes Fernández, Antonio Delgado, Antonio Gutierrez, Manuel Ojeda and Jaime Román.

Also participated in the conferences Esther Tallón, head of section of pharmaceutical supplies of the SAS, which referred to the professional implications of prescribing and dispensing active ingredient; Jaime Román Alvarado, community pharmacist, who exposed his vision of the community pharmaceutical care; and Gabriel Gómez star, doctor of the center of health in Morón de la Frontera, who spoke of his experience on médico-farmacéuticas relations in primary care.

Read More

The clinic Recoletos Cuatro of Valladolid, pioneer in Castile and León, Spain in digital dentistry.

|

La Clínica Recoletos de Valladolid four, pioneer in Castilla y León in dental digital.

scanner intraoral LAVA COS key in achieving a real stream digital.

Madrid, July of 2011- the application of new technologies in dentistry always presents a challenge and opens the door to evolution. The incorporation of digital technology represents a new way of working and raises expectations much more demanding and rewarding both for the dentist and the patient. In this sense, 3 M special has revolutionized the industry with the development of your intra-oral scanner LAVA COS, the first in the market that also scans implants. This solution replaces conventional printing techniques and represents a qualitative change in the work of dentists and dental technicians, allowing to transform the current clinical processes in a workflow of digital processes.

One of the clearest examples of the evolution towards the true digital flow is found in the clinic Recoletos four of Valladolid, one of the most advanced dental clinics of Spain. Dr. Julio Galván, director of this Center, worked for years with the most cutting-edge technology and has a great team of specialists in each discipline dental: doctors, nurses, hygienists, assistants and technical. A few months ago he decided to incorporate the intraoral scanner LAVA COS of 3MESPE and the experience has been really positive so far.

. According to Dr. Julio Galván, “ the team of professionals in the clinic knows perfectly the functioning of the intraoral scanner LAVA COS and is involved in its management. We also have extraoral dental scanner (i-CAT), by which we are pioneers in the fusion of images of both scanners for diagnosing and planning of minimally invasive surgery, computer-guided treatments “.

3 M special LAVA C0S scanner allows to perform radiological studies with the utmost precision, captures data directly from the mouth of the patient, as a sequence of video, and transforms them into images thanks to the 3D in motion technology.

So far, the only option was to use take a cast of teeth by means of a bucket with a filler of printing, which is uncomfortable for the patient, most laborious for the dentist and the laboratory technician and above all, we know that it is a less precise method.

the benefits of the system of digital printing through the intraoral scanner LAVA COS 3 M special are:

1 Reduces the time of printing (41% on average) taking.

2 Removes the realization of dental plaster models, creating digital virtual models captured directly from the mouth, avoiding intermediate steps and possible errors in them.

3 Reduces the need for repeat or duplicate models for the various phases of work, to use a single digital model not alterable (reducing errors by dislocations in an 89% average)

II Symposium Espertise participants: new materials, new options. New solutions in Digital dentistry, which will take place the 10th of September in the Teatro Fernán Gómez in Madrid, will know first-hand the best practices and experiences in the field of digital dentistry. There will meet the best professionals in the sector who offer the keys to understand why the impact of digitization on the dentistry is increasing.

If you are interested in attending the Congress, can register here.

May also request additional information in the technical secretariat:

phone: 91 204 42 19

ESPERTISE

this symposium is part of the Espertise programmes that were born with the aim of helping professionals in the sector to be aware of the continuous changes that occur in techniques, materials, etc., 3 M special has developed training Espertise programmes. These programs allow the exchange of knowledge and information among scientists, clinical researchers in materials and dental professionals.

About 3 M

3 M, founded in 1902, has more than 60,000 different items on the market. 3 M is a global multi-technological company, multi-producto and multi-mercado which operates in over 65 countries and has factories in 35 countries. The company, headquartered in Minnesota, has approximately 75,000 employees and turnover in 2009 US $ 23 billion.

Within the Division of health care of the company is 3 M special aimed at practitioners of dentistry. With a history of more than 40 years in the sector boasts worldwide reputation and takes the lead in providing innovative solutions for the dental industry, creating trend in the market.

3 M special manufactures and markets more than 2000 products used by dentists from around the world to improve the dental health of the population. The products are designed to meet their needs in the fields of restoration, prosthesis, prevention, control of infection and dental cosmetics.

Read More

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips

Surah Al-Rehman – The Ultimate Free Remedy for Incurable Diseases

(By Listening Only- 20 Minutes Only)

Kindly download the Surah “AL-REHMAN” (recited by Qari Abdul Basit without translation) from here.


Treatment Plan

Just Listen to it three times a day (morning, afternoon, evening) for seven consecutive days using following procedure:-


    Before listening:

  • Close your eyes
  • Feel your self in front of ALLAH Almighty/ God
  • Then listen to it with greater concentration and closed eyes

    When the recitation/ AUDIO is finished:

  • Open your eyes and take half glass of water
  • Close your eyes again and say “ALLAH” three times in your heart with deep affection/ love
  • Then drink the water with closed eyes in three sips